Does Medicare cover HER2-Positive Breast Cancer treatment including clinical trials

Medicare Coverage for HER2-Positive Breast Cancer Treatment

I'll help you understand what Medicare typically covers for HER2-positive breast cancer, including clinical trials. This is important information for planning your care and managing costs.

Standard HER2-Positive Breast Cancer Treatments

Medicare generally covers FDA-approved treatments for HER2-positive breast cancer, including:

• Anti-HER2 therapies like trastuzumab (Herceptin) and pertuzumab (Perjeta)
• Newer antibody-drug conjugates like trastuzumab deruxtecan (Enhertu), which the FDA recently approved for HER2-positive breast cancer
• Chemotherapy combinations used alongside targeted therapies
• Hormone therapies if your cancer is also hormone receptor-positive
• Imaging and monitoring (CT scans, MRI, PET scans)

According to the CancerPatientLab webinars on proteomic testing and personalized cancer treatment, trastuzumab deruxtecan (Enhertu) has opened new treatment doors, particularly for patients with varying HER2 expression levels. This drug is now FDA-approved and represents an important advancement in HER2-positive breast cancer care.

Clinical Trial Coverage

Medicare coverage of clinical trials is more complex:

✅ Medicare DOES cover:

• Standard care treatments given within a clinical trial
• Routine care costs (doctor visits, lab tests, imaging)
• Hospitalization related to the trial
• Travel reimbursement for trials at NCI or NIH facilities

❌ Medicare typically DOES NOT cover:

• Investigational drugs or devices that are still being tested (in some cases)
• Some experimental procedures
• Costs specific to research that wouldn't occur in standard care

Important Coverage Considerations

Coverage can vary based on:

• Your specific Medicare plan (Original Medicare vs. Medicare Advantage)
• Whether the clinical trial is:
  • Sponsored by the National Cancer Institute (NCI)
  • FDA-regulated
  • Part of an approved research program

According to Chris Beardmore's webinar on accessing cancer treatments, "There are a lot of barriers, even when a patient brings a ton of data to the table with recommended treatment options." This underscores why it's important to understand your coverage upfront.

What You Should Do

Before starting any treatment or enrolling in a clinical trial:

1. Call Medicare directly at 1-800-MEDICARE to ask about:

   • Coverage for your specific treatment plan
   • Whether a particular clinical trial is covered
   • Your out-of-pocket costs

2. Ask your oncology team:

   • "Is this treatment covered by Medicare?"
   • "If I enroll in a clinical trial, what costs will Medicare cover?"
   • "Are there patient assistance programs if Medicare doesn't cover something?"

3. Get it in writing - Request written confirmation of coverage before treatment begins

4. Explore patient assistance programs - According to the webinars, pharmaceutical companies often provide free or discounted medications through patient assistance programs, even when insurance coverage is limited

Real-World Example

The webinars describe a case of an 81-year-old woman with metastatic, hormone-positive breast cancer with low HER2 amplification. When her insurance initially wouldn't cover a newer HER2-targeted treatment, the pharmaceutical company (AstraZeneca) made the drug available free of charge through a patient assistance program. This shows that coverage barriers can sometimes be overcome.

Key Questions to Ask Your Healthcare Team

1. "Which HER2-positive breast cancer treatments does my Medicare plan cover?"
2. "If I want to participate in a clinical trial, how will Medicare cover the costs?"
3. "Are there any newer treatments (like Enhertu) that Medicare covers for my specific HER2 status?"
4. "What patient assistance programs are available if Medicare denies coverage?"
5. "Can you help me appeal if Medicare denies coverage for a recommended treatment?"

---

This information is for educational purposes only. Always consult your healthcare team and Medicare directly for personalized coverage information and decisions about your specific treatment plan.